Introduction Perioperative care of vestibular schwannoma (VS) patients is extremely variable across surgeons and institutions making practice patterns difficult to standardize. No data currently exist detailing this practice variability. Methods The North American Skull Base Society membership was electronically surveyed regarding perioperative care of surgically operated VS patients. Results There were 87 respondents to the survey. Surgical positioning, surgical approach utilized, and perioperative medical adjuncts are quite variable. However, of those performing retrosigmoid approaches, 49% perform this in the supine position, while 33% use a park-bench position with only 2% using the sitting position. In those performing translabyrinthine approaches, 86% perform this in supine position. Although the use of neuromonitoring appears to be standard of care (98%), other than the seventh nerve, there is substantial variability between respondents regarding monitoring of additional cranial nerves. Postoperative antibiotics are used by 65%, postoperative steroids 81%, and postoperative chemical deep vein thrombosis prophylaxis in 68% of survey respondents. Conclusion Although the perioperative adjuncts to VS surgery are variable, there does appear to be a trend in common practice. Therefore, making surgeons aware of these trends may lead to standardized practice or alternatively trials of these variances to instruct which truly improve patient outcomes.
Introduction
The perioperative details of current vestibular schwannoma (VS) surgery are not well described. First, there is no crosssectional study that has looked at the variance in patterns of surgical positioning, approach preference (translabyrinthine [TL] vs. retrosigmoid [RS] ), use of rigid cranial fixation, intraoperative procedural details, nor perioperative medical adjuncts. This study is part 2 of a cross-sectional electronic survey of the North American Skull Base Society (NASBS) to help define perioperative practice variance among surgeons who routinely perform VS microsurgical resection.
Materials and Methods
A 64-item Web-based survey assessing VS practice trends was devised by members of the NASBS Research Task Force and distributed to the NASBS membership via SurveyMonkey (►Appendix A, online only). Voluntary participation was solicited via e-mail with an attached electronic survey link available from November 29 through December 14, 2016 . Following initial contact, survey reminders were sent 1 week and 24 hours before survey closure.
Responses were requested from those who are engaged in VS treatment. As a secondary screening measure, the first question of the survey inquired, "Are you actively involved in VS treatment at your center?" and the survey episode was subsequently closed for respondents who selected "no." All survey questions were multiple choice, and in most cases, survey items required selection of the single best answer. Respondent data were collected and compiled anonymously. Data from this large survey were apportioned into two separate reports according to topic: (1) overall management trends in VS across North America and (2) practice patterns of perioperative VS care in North America. This article presents data for the second of these two publications. Descriptive statistical analysis was performed using Microsoft Excel (Redmond, Washington, United States). Associations between features of interest were analyzed using Spearman's rank correlation, and comparisons between variables were assessed using KruskalWallis's, Wilcoxon's rank-sum, and Fisher's exact tests as appropriate. Statistical analyses were performed using version 9.4 of the SAS software package (SAS Institute, Cary, North Carolina, United States). All tests were two sided and p-values <0.05 were considered statistically significant. The Mayo Clinic Institutional Review Board deemed this study exempt from review. (In final text, plan will be to cite article of one of this series for methods.)
Results

Survey
There were 87 respondents to the survey; surveys were sent to 719 e-mails which are the whole membership of NASBS as of October 2016. This membership includes neurosurgeons, otologist, radiation oncologist, ophthalmologist, and plastic surgeons; therefore, the lower response rate likely has to do with responses only from those managing VS.
Perioperative Details of Surgical Approach ►Table 1 provides a summary of details relative to differences between surgeon preferences for RS compared with TL approaches, middle fossa approaches were considered separately. In RS craniotomies (question 36), 49% of surgeons utilized a supine position, 33% a lateral decubitus position, 14% vary between these two cases depending on the case, and only 2% reported utilizing a sitting position. Comparatively, in TL (question 37) cases, 86% of surgeons utilized a supine position, 5% a lateral decubitus position, and 5% varied between these two positions depending on the case. Surgeons reported the use of a cerebellar retractor routinely in RS cases 42% of the time (question 34), and in TL cases in only 14% of cases, while 53% never use cerebellar retraction in TL cases (question 35). Rigid fixation of the head, usually via three-point pinion fixation (question 33) was reported in 86% of RS operations, 26% of TL, 42% of middle fossa approaches, and 11% report no use of rigid head fixation.
An endoscope was not used (question 40) exclusively to remove a VS by any respondent. However, 37% of surgeons reported using it in select situations such as when attempting hearing preservation, and 63% never used an endoscope as an adjunct to the procedure. Tumor debulking was performed utilizing ultrasonic aspiration 83% of the time, tumor forceps and suction 9%, scissors 5%, and other microdebridment Closure RS craniotomies were closed most commonly with replacement of the native bone flap (58%). Titanium mesh was used to replace a craniectomy defect 26% of the time, no reconstruction of the craniectomy was performed 4% of the time, and "other" was used in 12%. Of interest, no respondents reported using bone cement (question 43). Following TL approaches, titanium mesh (25%) was used most often to aid closure, followed by native bone (9%), absorbable mesh (9%), and bone cement was used 5% of the time (question 44).
As expected, a fat graft was utilized in 95% of TL cases. Primary approximation of dural leaflets was reported in 37% of cases, and 21% used artificial dural substitutes following TL surgery. Surgeons reported the following methods to prevent cerebrospinal fluid (CSF) leak associated with TL resection of VS: 65% pack the Eustachian tube with muscle or fascia at closure, 42% block the mastoid antrum with fascia, and 4% report oversewing the ear canal and packing the Eustachian tube at the time of primary surgery (question 44). Fifty-four percent surveyed report using a head wrap in the early postoperative phase after TL.
Neuromonitoring
Seventy-nine percent of respondents reported utilizing a separate neurophysiology team during surgery, while 21% utilized commercial products such as the NIMs (Medtronic Inc., Minneapolis, Minnesota, United States) monitor for cases which does not require a separate monitoring technician (question 24). When presented with a theoretical situation of a medium-sized VS < 2.5 cm (question 25) surgeons reported monitoring the trigeminal motor nerve (V3-Motor) in 32% of cases, facial nerve 98% of the time, vagus nerve (X) 12%, spinal accessory nerve (XI) 12%, and hypoglossal nerve (XII) in 4% of cases (see ►Table 2). In surgeons performing hearing preservation surgery, 72% reported using far field eighth nerve monitoring (brain stem auditory evoked response), 16% reported using direct eighth nerve monitoring (cochlear nerve action potentials), and 12% did not monitor the eighth nerve (see ►Table 2).
Immediate Postoperative Management
Antibiotics were used 65% of the time postoperatively, while 35% reported never using postoperative antibiotics (question 61). In those who used postoperative antibiotics, 42% used them for only 24 hours, 23% for 1 to 3 days after surgery, 4% for 4 to 7 days after surgery, and 2% for more than a week (question 62). Steroids were prescribed (question 58) following removal of a VS most commonly for 4 to 7 days (32%), for 8 to 14 days in 30% of patients, for 1 to 3 days in 19% of cases, and steroids were reportedly never used by 19% of surgeons who replied to the survey. Chemical deep vein thrombosis (DVT) prophylaxis was utilized in most patients (56% of the time). Also, in patients the surgeon deemed as "high risk" for DVT, an additional 12% of surgeons administered DVT prophylaxis. DVT prophylaxis was reported as rarely or never in 32% of respondents (question 59). DVT prophylaxis was initiated in those using it within 24 hours of surgery, 40% of the time; within 1 to 3 days, 28%; within 4 to 7 days, 4%; a week after surgery, 2%; and never, 26% (question 60). CSF leaks (question 53) were managed mostly with a lumbar drain (77%); however, conservative management (bed rest, lifting restrictions) was reported 9% of the time. Diamox was reported as being employed 2% of the time, and ear canal overclosure with packing of the Eustachian tube was reported by 12% of respondents to stop postoperative CSF leak as an initial treatment.
Facial Nerve Management
When a patient suffers profound facial weakness postoperatively, surgeons reported employing "aggressive" eye cares in 35% of cases as primary treatment for the symptoms of facial weakness, referred for upfront gold/platinum weight placement 49% of the time, and referred for upfront tarsorrhaphy 16% of the time (question 54). The perception of the cause of delayed facial weakness (question 55) was neural edema tracking up to the narrow labyrinthine segment of the facial nerve in 61%, reactivation of latent virus 19%, vasospasm in 18%, and free pulsation of CSF on the cisternal segment of the facial nerve after tumor removal 2% of the time. Surgeons reported using retroviral therapy to treat delayed facial weakness (question 56) postoperatively most of the time in 14%, sometimes (50%) in 11%, and rarely or never by 75% of the respondents.
Prolonged Follow-up
Thirty-seven percent of survey respondents reported getting their first postoperative magnetic resonance imaging (MRI) (question 63) < 48 hours after tumor resection, within a month by 7% of the surgeon, between 1 and 6 months (37%), between 7 and 12 months (9%), and after 1 year, 11% of surgeons obtained a first postoperative MRI scan. After surgery, respondents reported allowing patients to return to work within 2 weeks, 4% of the time; at 1 month, 28%; at 6 weeks, 47% of cases; at 3 months, 21%; and no respondent routinely recommended return to work beyond 3 months (question 64). Wound difficulties, and in particular CSF leak, are a significant concern for surgeons operating VS. Interestingly, there is significant variability in closure techniques following VS surgery. Following the TL approach, most surgeons use fat (95% of the time) to fill the mastoidectomy defect, while 34% augment the fat by using some type of mesh over the fat graft. There is also considerable inconsistency in the pattern of which individuals attempt to block CSF leakage with 65% of respondents packing the Eustachian tube with muscle or fat and 42% simply blocking the antrum; however, only 4% oversew the ear canal at the time of primary tumor resection. Interestingly enough, not even a head wrap is standardized where approximately 50% of people doing TL approach utilized head wraps postoperatively. In terms of RS craniotomies, 58% of the time native bone flap is replaced, while 26% of the time, a titanium cranial mesh reconstruction is utilized. Therefore, despite good evidence that cranioplasty decreases postoperative headaches in VS, this is not standard of practice still. [2] [3] [4] It is unknown as to whether or not these reconstruction techniques lead to differences in outcomes, however. Neuromonitoring appears to be standard in that nearly 98% of individuals monitor the seventh nerve during resection. Most surgeons report utilizing a separate monitoring team (79%), while 21% utilized commercial products such as a NIM monitor which are self-contained. 5 In the case of a theoretical mediumsized tumor, the next most commonly assessed nerve was the motor portion of V3, however, only utilized in 32% of cases. Additional monitoring such as the vagus nerve, spinal accessory nerve, or hypoglossal nerve was very infrequently utilized.
Therefore, it appears to be standard of care to monitor the seventh nerve, although additional nerves are up to surgeon preference. In a situation of which one is performing hearing preservation surgery, 72% utilized auditory brain stem response (ABR) or far field eighth nerve monitoring, while only 16% report utilizing direct eighth nerve monitoring and cochlear nerve action potential. However, still 12% did not utilize monitoring.
The variance in these techniques may also be institutional in that some forms of monitoring may be dependent on the neurophysiologist teams, performing the monitoring alternatively may not be available at some institutions. 6 Whether these are standard is a matter of debate as ABRs are often difficult to interpret intraoperatively and dropout well after hearing has changed, and further direct eighth nerve monitoring is not always possible depending on the position of the tumor.
7,8
Wound infection and meningitis can be devastating complications associated with VS removal, regardless of size or technique.
9 Interestingly, although, most would recommend antibiotics for at least a 24-hour period postoperatively, postoperative antibiotic use was only reported by 65% of surgeons, while 35% reported never utilizing postoperative antibiotics (►Table 3). There is variance, also, as to how long antibiotics were given postoperatively with 42% giving them for the traditional perioperative three doses in a 24-hour period, while 4% reported 4 to 7 days or longer in some circumstances. This variance does not fall in line with most recent recommendations for standard practices care: Typically, the recommended peri-intraoperative dose is within 60 minutes of skin incision in addition to two postoperative doses of antibiotic covering skin flora. 10 There currently exists no literature around perioperative antibiotics in VS cases; however, there are data to suggest bacitracin irrigation reduces rates of postoperative infection.
11 Perioperative steroid use is very controversial, some use it to aid in controlling headaches and reduce inflammation of the seventh nerve; however, some choose to not utilize steroids for fear of secondary complications such as infection, poor wound healing, ulcers, and other medical consequences. Steroid use is very common postoperatively, although certainly not standard in this cohort. Only 19% of respondents did not use postoperative steroids; they were utilized most commonly for 4 to 7 days postoperatively. Perhaps, the most interesting of variable practice parameter assessed was DVT prophylaxis which was utilized 56% of the time, an additional 12% of surgeons reported using DVT prophylaxis in only high-risk patients, and 32% reported never using chemical DVT prevention. Most surgeons reported using DVT prophylaxis within 24 hours of surgery. Very little data are available, currently, to suggest if there is an increased risk of perioperative hematoma formation with the use of postoperative chemical DVT prophylaxis. However, recent meta-analyses demonstrate probably a significant reduction in DVTs with a detectable increase in postoperative hematoma.
12
Further, in this study, we did not assess the specific type of DVT prophylaxis utilized. Perhaps, one of the most interesting aspects of this study was polling VS surgeons and assessing what they believe was the primary cause for postoperative delayed facial nerve weakness. Approximately 61% reported this was likely edema tracking along the facial nerve, while only 19% reported reactivation of latent herpes virus and 18% suspected vasospasm. Although the mechanism of this remains undetermined, the neural edema appears to be most frequently cited. There are individual case reports of each mechanism being the primary cause. 13 This number is interestingly very close to the number of respondents utilizing steroid for treatment and may, in fact, impact this delayed facial weakness. Although the majority of respondents have reported use of corticosteroids to prevent postoperative facial weakness, there is a double-blind, placebo-controlled trial demonstrating it did not do so.
14 In terms of retroviral therapy treating possible reactivation of herpes virus, this was used rarely or never in 75% of the patients. Further, the follow-up was extremely variable at which time the first postoperative MRI was most frequently performed. The most common time surgeons reported obtaining the first postoperative MRI scan was either within the first 48 hours (37%) or between 1 and 6 months postoperatively (also 37% of the time). In cases of gross total resection, this is perhaps the most sensible place to start with practice standardization to reduce cost and establish standards for follow-up to determine recurrence, especially in cases without evidence of linear or nodular postoperative enhancement. 15 We did not assess more long-term imaging surveillance patterns among respondents. Future surveys and analysis might benefit from further delving into the differences surgeon's may feel represent acceptable facial nerve outcomes, what is considered useful hearing and what criteria various surgeons use to define near total or subtotal resections (►Table 3).
Conclusion
Although the perioperative adjuncts to VS surgery are variable, there does appear to be a trend in common practice. Therefore, making surgeons aware of these trends may lead to standardized practice. Alternatively, trials of these variances to instruct us as to which practice patterns truly improve patient outcomes such as perioperative steroid use, DVT prophylaxis, and antibiotic treatment. Awareness is the first step to standardization and practice improvement which this series of articles initiates; there is still a fair amount of work to be done to produce practice standards.
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